This study is testing a medication called ziltivekmab to see if it can help people with heart failure.

This study is testing eplontersen as a treatment for Cardiac Amyloidosis.

The purpose of this study is to survey patients on their experiences being treated for Severe Aortic Stenosis

This study is comparing two ways of treating Atrial Fibrillation (AF). Patients will either take continuous anticoagulation medications, or they will wear AF-sensing smartwatches and take anticoagulation medications for 30 days after an AF event.

The presence of certain genetic factors in some patients protects them from developing coronary artery disease (CAD). This study seeks to identify these protective genetic factors and to expand our understanding of the genetic contribution to the development of CAD.

We are seeking to improve knowledge around treatment of atrial fibrillation for primary care providers and patients through educational interventions.

Study the effects of a new drug LY3540378 in patients with heart failure

We are doing this study to look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with obesity and cardiovascular disease.

We are reaching out to patients who were hospitalized at UNC and are also eligible for cardiac rehabilitation. We want to learn more about what the barriers are to attending cardiac rehabilitation. Did you not know it existed? Did the time commitment seem too much? What other questions did you have?

Study the effects of Ponsegromab a new drug in patients with heart failure